2022 Global Genomic Cancer Panel and Profiling Market Report - by Cancer, Application, Tissue and Gene Type - ResearchAndMarkets.com

·4 min read

DUBLIN, January 24, 2022--(BUSINESS WIRE)--The "Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening potential Market Size, Forecasting/Analysis, and Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.

This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2021 United States Medicare Fee Payment Schedules to help understand test pricing in detail. Forecast demand for new testing regimes or technologies.

Make research investment decisions. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.

Cancer Gene Panels and Genomic Profiling are quickly changing the diagnosis and treatment of cancers. The market is moving out of a specialized niche and going mainstream as Oncologists begin routinely using information on the hundreds of genes related to cancer. The market is exploding as physicians use all the information they can get in the battle against cancer.

While Pharmaceutical Companies see the potential to make nearly any therapy viable. The report has data on how test volumes have grown for the biggest players. Find out how this new way of understanding cancer will change cancer diagnostics forever.

Comprehensive panels, genomic profiling, high risk breast cancer panels. Learn all about how players are jockeying for position in a market that is being created from scratch. And some players are pulling way out in front and expanding globally. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing. And the science is developing at the same time creating new opportunities with regularity. And the cost of sequencing continues to fall.

Key Topics Covered:

1 Market Guides

1.1 Cancer Panel Market - Strategic Situation Analysis & COVID Update

1.2 Large Comprehensive Cancer Panel Market - Situation Analysis

1.3 Guide for Executives, Marketing, Sales and Business Development Staff

1.4 Guide for Management Consultants and Investment Advisors

1.5 Market Size and Shares - Large Comprehensive

2 Introduction and Market Definition

2.1 What are Cancer Gene Panels and Profiling?

2.2 The Sequencing Revolution

2.3 Market Definition

2.3.1 Revenue Market Size

2.4 Methodology

2.4.1 Authors

2.4.2 Sources

2.5 A Spending Perspective on Clinical Laboratory Testing

2.5.1 An Historical Look at Clinical Testing

3 Market Overview

3.1 Players in a Dynamic Market

3.1.1 Academic Research Lab

3.1.2 Diagnostic Test Developer

3.1.3 Instrumentation Supplier

3.1.4 Distributor and Reagent Supplier

3.1.5 Independent Testing Lab

3.1.6 Public National/regional lab

3.1.7 Hospital lab

3.1.8 Physician Office Labs

3.1.9 Audit Body

3.1.10 Certification Body

3.2 Oncogenomics

3.3 Cancer Management vs. Diagnosis

3.4 Phases of Adoption - Looking into The Future

3.5 Structure of Industry Plays a Part

3.5.1 Hospital Testing Share

3.5.2 Economies of Scale Hospital vs. Central Lab

3.5.3 Physician Office Lab's

3.5.4 Physician's and POCT

3.6 Currently Available Large Comprehensive Assays

3.7 Pricing Profiling vs. Whole Exome (or Genome) Sequencing

3.7.1 Medicare Profile Pricing

3.7.2 Whole Exome Sequencing

4 Market Trends

4.1 Factors Driving Growth

4.1.1 Level of Care

4.1.2 Companion Dx

4.1.3 Immuno-oncology

4.1.4 Liability

4.1.5 Aging Population

4.2 Factors Limiting Growth

4.2.1 State of knowledge

4.2.2 Genetic Blizzard

4.2.3 Protocol Resistance

4.2.4 Regulation and coverage

4.3 Instrumentation and Automation

4.3.1 Instruments Key to Market Share

4.3.2 Bioinformatics Plays a Role

4.4 Diagnostic Technology Development

4.4.1 Next Generation Sequencing Fuels a Revolution

4.4.2 Single Cell Genomics Changes the Picture

4.4.3 Pharmacogenomics Blurs Diagnosis and Treatment

4.4.4 CGES Testing, A Brave New World

4.4.5 Biochips/Giant magneto resistance based assay

5 Cancer Panels & Profiles Recent Developments

6 Profiles of Key Players

7 The Global Market for Cancer Gene Panels and Profiles

8 Global Cancer Gene Panels & Profiles Markets - By Type of Cancer

9 Global Cancer Gene Panels & Profiles Markets - By Type of Application

10 Global Cancer Gene Panels & Profiles Markets - By Tissue Type

11 Global Cancer Gene Testing Markets - Germline and Somatic

12 Potential Market Opportunity Sizes

13 Appendices

For more information about this report visit https://www.researchandmarkets.com/r/pb4hhk

View source version on businesswire.com: https://www.businesswire.com/news/home/20220124005492/en/


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900